Cargando…
An acute immune response underlies the benefit of cardiac stem cell therapy
Clinical trials using adult stem cells to regenerate damaged heart tissue continue to this day(1,2) despite ongoing questions of efficacy and a lack of mechanistic understanding of the underlying biologic effect(3). The rationale for these cell therapy trials is derived from animal studies that show...
Autores principales: | Vagnozzi, Ronald J., Maillet, Marjorie, Sargent, Michelle A., Khalil, Hadi, Johansen, Anne Katrine, Schwanekamp, Jennifer A., York, Allen J., Huang, Vincent, Nahrendorf, Matthias, Sadayappan, Sakthivel, Molkentin, Jeffery D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962570/ https://www.ncbi.nlm.nih.gov/pubmed/31775156 http://dx.doi.org/10.1038/s41586-019-1802-2 |
Ejemplares similares
-
TGFBI functions similar to periostin but is uniquely dispensable during cardiac injury
por: Schwanekamp, Jennifer A., et al.
Publicado: (2017) -
Nemo-Like Kinase (NLK) Is a Pathological Signaling Effector in the Mouse Heart
por: Liu, Ruijie, et al.
Publicado: (2016) -
ERK1/2 signaling induces skeletal muscle slow fiber-type switching and reduces muscular dystrophy disease severity
por: Boyer, Justin G., et al.
Publicado: (2019) -
Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart
por: Fu, Xing, et al.
Publicado: (2018) -
c-kit(+) Cells Minimally Contribute Cardiomyocytes to the Heart
por: van Berlo, Jop H., et al.
Publicado: (2014)